Alamar Biosciences, Inc. (California) (ALMR)
24.18
-1.09
(-4.31%)
USD |
NASDAQ |
Oct 12, 16:00
24.28
+0.10
(+0.41%)
After-Hours: 20:00
Alamar Biosciences Free Cash Flow (Quarterly) : -15.07M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.07M |
| March 31, 2026 | -21.12M |
| Date | Value |
|---|---|
| June 30, 2025 | -13.00M |
| March 31, 2025 | -14.05M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Personalis, Inc. | -29.55M |
| 10X Genomics, Inc. | 15.39M |
| Adaptive Biotechnologies Corp. | -7.584M |
| Champions Oncology, Inc. | -0.547M |
| Medpace Holdings, Inc. | 138.10M |